Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for ASP Isotopes (ASPI) over the last 4 years, with Q3 2025 value amounting to $113.9 million.

  • ASP Isotopes' Cash & Equivalents rose 12094.0% to $113.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.9 million, marking a year-over-year increase of 12094.0%. This contributed to the annual value of $61.9 million for FY2024, which is 68260.79% up from last year.
  • ASP Isotopes' Cash & Equivalents amounted to $113.9 million in Q3 2025, which was up 12094.0% from $67.7 million recorded in Q2 2025.
  • Over the past 5 years, ASP Isotopes' Cash & Equivalents peaked at $113.9 million during Q3 2025, and registered a low of $431565.0 during Q3 2022.
  • Over the past 4 years, ASP Isotopes' median Cash & Equivalents value was $7.9 million (recorded in 2023), while the average stood at $28.8 million.
  • In the last 5 years, ASP Isotopes' Cash & Equivalents skyrocketed by 2888.86% in 2023 and then skyrocketed by 215517.87% in 2024.
  • ASP Isotopes' Cash & Equivalents (Quarter) stood at $2.4 million in 2022, then soared by 231.01% to $7.9 million in 2023, then skyrocketed by 682.61% to $61.9 million in 2024, then soared by 84.1% to $113.9 million in 2025.
  • Its Cash & Equivalents was $113.9 million in Q3 2025, compared to $67.7 million in Q2 2025 and $56.0 million in Q1 2025.